Please login to the form below
National Cancer Institute
This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.
Gottlieb signs off with flair – and pledge of further drug price commentary
He now hands over to interim FDA commissioner Ned Sharpless, formerly head of the National Cancer Institute (NCI), but ended his final days in the post with a redoubled focus on
Latest news
-
Second chance for AstraZeneca’s selumetinib with breakthrough designation
The news is a welcome turn around for the molecule, which failed in a phase 3 trial in non-small cell lung cancer (NSCLC) back in 2016. ... These results were presented by the National Cancer Institute (NCI) at last year’s ASCO congress, and the drug
-
Gottlieb admonishes industry for clinical trial failings
Gottlieb – who is leaving the FDA next month and will be replaced on an interim basis by National Cancer Institute (NCI) director Ned Sharpless – says that the advent in precision medicine, ... study of neoadjuvant and personalised drugs for breast
-
NCI head Sharpless named as interim FDA chief
The search for a permanent replacement is still ongoing. The head of the National Cancer Institute (NCI, Ned Sharpless, is the Trump administration’s pick to serve as acting FDA commissioner ... Sharpless has headed up the NCI since October 2017, and
-
AZ nabs US approval for new leukaemia drug Lumoxiti
National Cancer Institute (NCI) in the US, the lead investigator in the study. ... Seattle Genetics/Takeda’s classical Hodgkin lymphoma therapy Adcetris (brentuximab vedotin) and Roche’s Kadcyla (trastuzumab emtansine) for breast cancer.
-
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
Professor David Marks, Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, and transplant co-ordinator of the National Cancer Research Institute (NCRI) Adult ALL Group said the
More from news
Approximately 1 fully matching, plus 81 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 3)
As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of
-
An effective commercial model for cancer care
Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information
-
EATRIS and the new age of partnering
In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -
-
Diagnostics are rising up the pharma value chain
According to the US National Cancer Institute, about 12 per cent of women in the general population will develop breast cancer sometime during their lives. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.
-
Country report: The healthcare market in France
National Cancer Institute (NCI) or the National Institute for Prevention and Education for Health (NIPEH). ... This applies to oncology drugs under France's national cancer care plan that includes fast access to new therapies.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Cancer Research UK's Karen Vousden to join BMS board
She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National ... Cancer Institute.
-
AZ and Medimmune bolsters immuno-oncology leadership
roles at the National Cancer Institute (NCI). ... Institut Gustave Roussy - a leading cancer-research institute.
-
Iris Pauporté joins OSE Immunotherapeutics
Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research
-
AstraZeneca appoints Sean Bohen as chief medical officer
Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the ... National Cancer Institute.
-
JPA adds to Washington team
He also managed public health communications programmes for the Food and Drug Administration and National Cancer Institute.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
HIV infection. Nat Rev Dis Primers. 2015; 1: 15035. National Cancer Institute. ... HIV infection and cancer risk. Available at: . Accessed November 2018. UCSF Health. AIDS diagnosis. Available at: . Accessed November 2018. Avert. Symptoms and stages of
-
Mastering the precision medicine opportunity
The National Cancer Institute and the Centre for Disease Control both use the 4Ps model to define precision medicine, considering it a form of evidence-based medicine that is:. ... Parallel to the increasing number of testing options is the evolving
-
ASCO 2015: What you missed in Chicago
Specifically, we thought the checkpoint inhibitors in head and neck, lung cancer and melanoma really shone. ... The second area that really impressed me was the large National Cancer Institute (NCI) trial[3] that will look to treat patients with solid
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
-
Account Director, Medical Education
-
Salary TBC
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Director – Healthcare PR
-
Salary TBC
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary and benefits
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
